GC
VYGR icon

Globeflex Capital’s Voyager Therapeutics VYGR Stock Holding History

Globeflex Capital’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-291,293
Closed -$1.65M – 470
2024
Q4 		$1.65M Hold
291,293
– – 0.14% 128
2024
Q3 		$1.7M Hold
291,293
– – 0.16% 128
2024
Q2 		$2.3M Sell
291,293
-18,215
-6% -$153K 0.24% 96
2024
Q1 		$2.88M Sell
309,508
-21,782
-7% -$184K 0.28% 83
2023
Q4 		$2.8M Sell
331,290
-122,305
-27% -$887K 0.29% 86
2023
Q3 		$3.52M Buy
453,595
+126,695
+39% +$1.16M 0.41% 65
2023
Q2 		$3.74M Buy
326,900
+290,791
+805% +$3.01M 0.42% 72
2023
Q1 		$278K Buy
+36,109
New +$287K 0.03% 316
2017
Q1 		– Sell
-57,430
Closed -$732K – 546
2016
Q4 		$732K Sell
57,430
-33,201
-37% -$426K 0.18% 209
2016
Q3 		$1.09M Buy
90,631
+50,401
+125% +$682K 0.27% 133
2016
Q2 		$442K Buy
40,230
+30
+0.1% +$367 0.12% 249
2016
Q1 		$351K Buy
+40,200
New +$456K 0.09% 269

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Globeflex Capital's VYGR Position: Q1 2025 in Review

Globeflex Capital sold out of Voyager Therapeutics (VYGR) in Q1 2025, closing a stake of 291,293 shares — an estimated $1.65M sold.

Globeflex Capital first reported a position in VYGR in Q1 2016 and held it in 12 quarters. The position peaked at $3.74M in Q2 2023. 116 funds tracked by Wall St. Rank hold VYGR as of Q1 2025.

  • Globeflex Capital reported no remaining Voyager Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Globeflex Capital sold 291,293 Voyager Therapeutics shares in Q1 2025, an estimated $1.65M.
  • Globeflex Capital first reported a position in Voyager Therapeutics in Q1 2016 and held it in 12 quarters.
  • Globeflex Capital's Voyager Therapeutics position peaked at $3.74M in Q2 2023.
  • 116 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2025.

Based on Globeflex Capital's 13F filing for Q1 2025, filed 12 May 2025.